Birmingham, West Midlands -- (SBWIRE) -- 12/05/2013 -- Value Penny Stocks issues special report on: Lehigh Gas Partners (NYSE:LGP), Puma Biotechnology Inc (NYSE:PBYI), Forest Oil Corporation (NYSE:FST), Novavax, Inc. (NASDAQ:NVAX)
Lehigh Gas Partners (NYSE:LGP) was trading lower by -1.15 points or -4.07% to $27.12.So far, around 1.32 million shares have changed hands in this session. After opening at $26.68, the stock hit as high as $27.21. However, it traded between $16.66 and$29.18 over the last twelve months. Lehigh Gas Partners LP is engaged in the wholesale distribution of motor fuels, consisting of gasoline and diesel fuel, and to own and lease real estate used in the retail distribution of motor fuels.
Has LGP Found The Bottom and Ready To Move Up? Find Out Here
Puma Biotechnology Inc (NYSE:PBYI) was at $72.49, showing a 56.87% increase. Around 1.90 million shares have been traded, versus an-average trading volume of 186,163.00 shares. The company is now valued at around $2.08 billion. Puma Biotechnology, Inc. is a development-stage biopharmaceutical company that acquires and develops products for the treatment of various forms of cancer.
For How Long PBYI Gloss will Attract Investors? Find out via this report
Forest Oil Corporation (NYSE:FST) moved -1.99 per cent lower at $3.94 and is trading between $3.91 and $4.05 after opening the day at $3.91. Its performance over the last five days remained -10.57%, which stands at -10.77% for a month. Going back further than one month, 1-year performance after recent close was -41.18%.Forest Oil Corporation (Forest) is an independent oil and gas company engaged in the acquisition, exploration, development, and production of oil, natural gas, and natural gas liquids in North America.
Why Should Investors Buy FST After the Recent Fall? Just Go Here and Find Out
Novavax, Inc. (NASDAQ:NVAX) shares rose today, gaining 2.96 per cent to $4.13. The stock is up around 119.52% in 2013 and 127.97% for the last 12 months. Around 3.50 million shares changed hands so far in this session compared to an-average trading volume of 3.71M shares. Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines.
Why Should Investors Buy NVAX After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)